Innovent Biologics,Inc. is a leading biopharmaceutical company in China focused on the discovery, development and manufacturing of complex, high-end biologics for both the Asian and global markets that meet EMA and FDA/cGMP standards. Innovent has an expanding biologics pipeline focused on oncology, inflammatory diseases and ophthalmology. Innovent's strategy is to advance its internal pipeline of proprietary biologic drugs and establish in/out-licensing agreements with global pharmaceutical/biotech companies. Because of its location and emphasis on quality, Innovent is able to leverage China's cost-efficient environment without compromising its world-class quality standards.
Fangshan Qu, CN
Size (employees)
177 (est)+5%
Innovent Biologics was founded in 2011 and is headquartered in Fangshan Qu, CN
Report incorrect company information

Innovent Biologics Office Locations

Innovent Biologics has an office in Fangshan Qu
Fangshan Qu, CN (HQ)
Dong Ping Jie
Show all (1)
Report incorrect company information

Innovent Biologics Financials and Metrics

Summary Metrics

Innovent Biologics's latest funding round in November 2016 was reported to be $260 m. In total, Innovent Biologics has raised $385 m
Report incorrect company information